{"id":"W2099555993","doi":"10.3899/jrheum.090307","title":"Sarcoidosis During Anti-Tumor Necrosis Factor-α Therapy: No Relapse After Rechallenge","year":2009,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Sarcoidosis; Rheumatoid arthritis; Adverse effect; Neurosarcoidosis; Tumor necrosis factor alpha; Dermatology; Erythema nodosum; Arthritis; Internal medicine; Immunology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001070059,0.0006304653,0.002119526,0.0007119745,0.0002110184,0.00006316671,0.000895326,0.001087692,0.001257736],"category_scores_gemma":[0.0003798977,0.0003700576,0.0008561573,0.0003233505,0.0003699419,0.0001587817,0.0001480562,0.006285231,0.0002832904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002296173,"about_ca_system_score_gemma":0.0003871791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001320289,"about_ca_topic_score_gemma":0.00001219698,"domain_scores_codex":[0.9949797,0.0009374471,0.001447239,0.000383848,0.001236778,0.001014949],"domain_scores_gemma":[0.9961145,0.0007874561,0.001162362,0.0009744237,0.000737507,0.0002237806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006043364,0.000689194,0.08240922,0.001198081,0.002378924,0.004403834,0.001541026,0.000001310585,0.01201644,0.000005660288,0.8847489,0.004564043],"study_design_scores_gemma":[0.01430126,0.006751277,0.1445199,0.006146506,0.001368303,0.1511944,0.0002874938,0.00002344642,0.007430848,0.0005175832,0.6654398,0.002019036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6566019,0.006478588,0.000005572934,0.3356953,0.0005696737,0.0003478977,0.00001629515,0.00002907134,0.0002557184],"genre_scores_gemma":[0.7838379,0.06658451,0.0001783938,0.146074,0.001028129,0.00001890186,0.00001318209,0.0001831686,0.002081772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.219309,"threshold_uncertainty_score":0.9998751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03369657219011801,"score_gpt":0.2902590389633183,"score_spread":0.2565624667732003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}